BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report)’s share price fell 1.4% on Tuesday . The company traded as low as $2.15 and last traded at $2.16. 6,790 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 30,130 shares. The stock had previously closed at $2.19.
BioNexus Gene Lab Price Performance
The company has a debt-to-equity ratio of 0.01, a current ratio of 6.53 and a quick ratio of 5.69. The stock has a market cap of $5.23 million, a price-to-earnings ratio of -1.46 and a beta of 4.06. The business’s 50-day simple moving average is $2.17 and its two-hundred day simple moving average is $2.87.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.23) earnings per share for the quarter. BioNexus Gene Lab had a negative net margin of 54.70% and a negative return on equity of 37.43%. The company had revenue of $0.02 million during the quarter.
Institutional Trading of BioNexus Gene Lab
BioNexus Gene Lab Company Profile
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
See Also
- Five stocks we like better than BioNexus Gene Lab
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
